CoQ10 oxidoreductases in ferroptosis and cancer: redox regulation and therapeutic opportunities

Jumi Lee, Inhwan Yoo, Minseok Kim, Hyeonseok Kim, Namgyu Lee · 2026

Read CoQ10 oxidoreductases in ferroptosis and cancer: redox regulation and therapeutic opportunities by Jumi Lee, Inhwan Yoo, Minseok Kim, Hyeonseok Kim, Namgyu Lee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13324536.txt.

Description

Jumi Lee and team review how CoQ10 oxidoreductases control ferroptosis and what that means for cancer therapy. Their 2026 paper explains that coenzyme Q10 is a shared fat-soluble redox helper that carries electrons in mitochondria and shields cells from oxygen stress. Growing evidence casts CoQ10 and its enzymes as critical drivers of ferroptosis, an iron-dependent cell death driven by lipid damage, making them attractive levers for treatment.

The review covers the main CoQ10 synthesis pathway and the known roles of its key enzymes, spotlighting cell-death-suppressing enzymes such as FSP1, DHODH, and SQOR, which regenerate reduced ubiquinol. It also surveys newly found CoQ10-related enzymes and their mechanistic contributions to cell-death control. By joining biochemistry, metabolism, and cancer biology, the authors position these enzymes as promising targets for cell-death-based cancer therapies, while noting that therapeutic translation still needs work.

Catalog record

CREATORJumi Lee, Inhwan Yoo, Minseok Kim, Hyeonseok Kim, Namgyu Lee
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE126 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13324536

Browse the full library · About the Tower of Babel